77 completed, 18 unknown, 15 terminated, 12 not yet recruiting. 131 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 131 | Completed 77, Unknown 18, Terminated 15, Not yet recruiting 12, Withdrawn 5, Recruiting 4 |
Follow Mycoses: new trials by email Literature Review of Mycoses trials Research Report on Mycoses
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparative Efficacy of Luliconazole and Bifonazole Combined With Itraconazole in Dermatophytosis Itraconazole, Luliconazole Cream 1%, Bifonazole cream 1% - Tinea Corporis, Tinea Cruris | Phase 4 | Not yet recruiting | University of Faisalabad | 182 | 2026-12-01 | 2026-11-12 |
| Emerging Indications for Hyperbaric Oxygen Treatment Hyperbaric oxygen treatment (HBOT), 100% Oxygen - Post-COVID-19 Condition, Ulcerative Colitis | Phase 4 | Not yet recruiting | Jay C. Buckey Jr. | 100 | 2026-11-01 | 2026-09-09 |
| Comparison of Itraconazole With Itraconazole and Isotretinoin in the Treatment Duration, Safety a n d Cure Rate in Adult Patients of Tinea Corporis/ Cruris-A Randomised Controlled Trail Itraconazole (200 mg), ISOtretinoin 20 MG - Tinea Corporis | Phase 4 | Not yet recruiting | Pak Emirates Military Hospital | 60 | 2026-10-01 | 2026-06-30 |
| Shortening Treatment Duration in Uncomplicated Candidemia: the CanTEN Trial Caspofungin only within the study, Caspofungin for 3 days within the study, Placebo only within the study - Candidemia, Invasive Candidiasis | Phase 4 | Not yet recruiting | Oliver Cornely, MD | 420 | 2026-09-01 | 2026-09-01 |
| Low- vs Standard-Dose TMP-SMX for Prevention of Pneumocystis Pneumonia After Kidney Transplantation Trimethoprim-Sulfamethoxazole (TMP-SMX) - Pneumocystis Jirovecii Pneumonia, Kidney Transplantation | Phase 4 | Not yet recruiting | Anhui Provincial Hospital | 1084 | 2026-06-01 | 2026-06-01 |
| Positioning Second-line Therapies for Pneumocystis Jirovecii Pneumonia (PCP Alternatives) Clindamycin + primaquine, Pentamidine, Atovaquone - Pneumocystis, Pneumocystis Infection | Phase 4 | Not yet recruiting | McGill University Health Centre/Research Institute of the McGill University Health Centre | 416 | 2026-03-01 | 2026-01-21 |
| Comparison of the Efficacy of Topical Luliconazole 2% Cream vs Topical Ketoconazole 1% Cream in the Treatment of Pityriasis Versicolor. Luliconazole Cream 1%, Topical ketoconazole 2% cream - Pityriasis Versicolor | Phase 4 | Not yet recruiting | PAEC General Hospital, Islamabad | 86 | 2026-02-01 | 2026-01-12 |
| Mycological Efficacy and Safety of Ketoconazole 2% Shampoo With a Seven-Day Versus Three-Day Treatment Duration in Pityriasis Versicolor Ketoconazole 2% Shampoo, Placebo Shampoo - Pityriasis Versicolor | Phase 4 | Not yet recruiting | Fakultas Kedokteran Universitas Indonesia | 76 | 2026-02-01 | 2026-03-13 |
| How Long Should we Give Steroids for Patients With Severe PCP Systemic corticosteroids - Pneumocystis Pneumonia, Pneumocystis | Phase 4 | Not yet recruiting | McGill University Health Centre/Research Institute of the McGill University Health Centre | 416 | 2026-01-30 | 2026-01-09 |
| Oral Fluconazole vs Oral Terbinafine for Tinea Capitis in Children Aged 2-10 Years Fluconazole., Terbinafine., Ketoconazole 2% shampoo - Tinea Capitis | Phase 4 | Completed | Dr. Amara Safdar | 64 | 2025-12-01 | 2026-11-10 |
| Comparing the Efficacy of Oral Fluconazole Versus Oral Itraconazole in Treating Resistant Tinea Corporis Itraconazole (200 mg), Fluconazole 150 mg - Tinea Corporis, Dermatophytosis | Phase 4 | Recruiting | Urooj Fatima | 126 | 2025-11-01 | 2026-01-15 |
| Comparison of Efficacy of Oral Fluconazole Versus Oral Itraconazole in the Treatment of Pityriasis Versicolor Fluconazole, Itraconazole - Pityriasis Versicolor | Phase 4 | Recruiting | Khyber Teaching Hospital | 106 | 2025-03-01 | 2025-04-10 |
| Efficacy of Tropical Sertaconazole Nitrate 2% Vs Clotrimazole 1% for Tinea Pedis Topical Sertaconazole 2%, Clotrimazole 1% - Tinea Pedis | Phase 4 | Not yet recruiting | Jinnah Postgraduate Medical Centre | 100 | 2025-03-01 | 2025-03-11 |
| Population Pharmacokinetics of L-AmB in Chinese Patients Assisted by Extracorporeal Membrane Pulmonary Oxygenation (ECMO) Determination of blood drug concentration - Invasive Fungal Infections, Liposomal Amphotericin B | Phase 4 | Not yet recruiting | Beijing Anzhen Hospital | 30 | 2025-01-10 | 2024-12-31 |
| Individualized First Maintenance Doses of Voriconazole Through a Multiparametric Algorithm Individualization of first voriconazole maintenance doses - Aspergillosis Invasive, Fungal Infection | Phase 4 | Not yet recruiting | University Hospital, Grenoble | 30 | 2024-10-01 | 2024-09-03 |
| Efficacy and Safety of Prophylactic Treatment for Pneumocystis Jirovecii Pneumonia in Patients With Autoimmune Inflammatory Rheumatic Disease Trimethoprim/Sulfamethoxazole - Pneumonia, Pneumocystis, Autoimmune Inflammatory Rheumatic Disease | Phase 4 | Recruiting | Tongji Hospital | 800 | 2024-07-20 | 2024-10-01 |
| Efficacy of Self Vs. Physician Application of Triamcinolone-Econazole in Otomycosis physician-applied Triamcinolone Acetonide Econazole Cream, patient-applied Triamcinolone Acetonide Econazole Cream - Otomycosis | Phase 4 | Completed | Zhongshan Hospital Xiamen University | 200 | 2024-06-01 | 2024-11-01 |
| A Clinical Study on the Efficacy and Safety of ABCD in the Treatment of Patients With Invasive Fungal Disease Amphotericin B cholesterol-sulfate complex for injection - Invasive Fungal Disease | Phase 4 | Unknown | Nanfang Hospital, Southern Medical University | 125 | 2024-04-01 | 2024-04-19 |
| Diode Laser and Photodynamic Therapy Vs. Ciclopirox. Diode laser combined with photodynamic-red laser therapy by RapidoPodia Laser Diodo®, Ciclopirox Hydroxypropyl Chitosan (HPCH) Nail Lacquer - Onychomycosis | Phase 4 | Unknown | Universidad Complutense de Madrid | 26 | 2023-09-01 | 2023-05-10 |
| 8% Sulphur-Aloe Vera Soap as an Adjuvant Treatment for Pityriasis Versicolor 8% sulphur and A. vera soap - Pityriasis Versicolor | Phase 4 | Completed | Universitas Padjadjaran | 42 | 2023-08-25 | 2024-03-26 |
Showing 20 of 131. Sign in to see all of them.
Invasive Fungal Infections (16) · Onychomycosis (16) · Candidiasis (14) · Aspergillosis (9) · Candidiasis, Invasive (9) · Pneumonia, Pneumocystis (9) · Tinea (9) · Candidemia (8) · Candidiasis, Vulvovaginal (8) · Tinea Versicolor (6) · Acquired Immunodeficiency Syndrome (5) · Meningitis, Cryptococcal (5) · Candidiasis, Oral (4) · Cryptococcosis (4)
Bacterial Infections and Mycoses (131) · Infections (128) · Skin and Connective Tissue Diseases (39) · Skin Diseases (38) · Skin Diseases, Infectious (36) · Dermatomycoses (34) · Pathological Conditions, Signs and Symptoms (26) · Candidiasis (21) · Respiratory Tract Diseases (20) · Urogenital Diseases (20) · Lung Diseases (19) · Tinea (19) · Genital Diseases (18) · Invasive Fungal Infections (17)
Fluconazole (15) · Micafungin (14) · Voriconazole (13) · Itraconazole (12) · Anidulafungin (8) · Caspofungin (7) · Amphotericin B (6) · liposomal amphotericin B (6) · Trimethoprim, Sulfamethoxazole Drug Combination (5) · Clindamycin (4) · Clotrimazole (4) · Ketoconazole (4) · posaconazole (4) · Ciclopirox (3) · Miconazole (3)
Pfizer (10) · National Institute of Allergy and Infectious Diseases (NIAID) (5) · Astellas Pharma China, Inc. (3) · Bausch Health Americas, Inc. (3) · Galderma R&D (3) · Mahidol University (3) · Merz North America, Inc. (3) · Peking University Shenzhen Hospital (3) · Gilead Sciences (2) · McGill University Health Centre/Research Institute of the McGill University Health Centre (2) · Merck Sharp & Dohme LLC (2) · Samsung Medical Center (2) · Texas Tech University Health Sciences Center (2) · University of Minnesota (2) · University of Pittsburgh (2)
United States (33) · China (20) · France (7) · Dominican Republic (6) · Germany (5) · Honduras (5) · Pakistan (5) · South Korea (5) · Spain (5) · Italy (4) · Thailand (4) · Belgium (3) · Brazil (3) · Canada (3) · India (3)
Anya Loncaric (3) · Shangrong Fan, M.D. (3) · Alan Fleischer, MD (2) · Boni E Elewski, MD (2) · Ronald Hall, PharmD, MSCS (2) · Afsoon Roberts, M.D. (1) · Alan B. Fleischer, MD (1) · Alberto M Borobia, MD, PhD (1) · Asuncion Moreno, MD (1) · Avner Shemer, MD (1) · Bharti R Daswani, MD, PhD (1) · Binu Alexander, MD (1)
PMID 28459966, PMID 28597967, PMID 31280481, PMID 33891293, PMID 10233295, PMID 10394018, PMID 10394019, PMID 10642676, PMID 11561801, PMID 12145716, PMID 12729424, PMID 14723731, PMID 1542320, PMID 19144094, PMID 20347657, PMID 21319349, PMID 21820203, PMID 22236569, PMID 22290953, PMID 22490643, PMID 22976905, PMID 23278851, PMID 23362285, PMID 23416171, PMID 23459494, PMID 23496375, PMID 23710653, PMID 23939898, PMID 24079583, PMID 24550378, PMID 24559321, PMID 24963568, PMID 25013957, PMID 25293517, PMID 25376267, PMID 25639524, PMID 25840339, PMID 25877666, PMID 26050015, PMID 26302738, PMID 26392095, PMID 26471716, PMID 27073145, PMID 27287231, PMID 27799043, PMID 27815659, PMID 28531175, PMID 30325463, PMID 30399034, PMID 30811142
5UL1RR024982-02 (2), 2008 (1), 2015 (1), 2019 (1), U01AI089244 (1), U01GH000517 (1)